Abstract

Atrial fibrillation (AF) is one of the most common supraventricular arrhythmias worldwide. However, the specific molecular mechanism underlying AF remains unclear. Our study is aimed at identifying pivotal microRNAs (miRNAs) and targeting genes associated with persistent AF (pAF) using bioinformatics analysis. Three gene expression array datasets (GSE31821, GSE41177, and GSE79768) and an miRNA expression array dataset (GSE68475) associated with pAF were downloaded. Differentially expressed genes (DEGs) were identified using the LIMMA package, and differentially expressed miRNAs (DEMs) were screened from GSE68475. Target genes for DEMs were predicted using the miRTarBase database, and intersections between these target genes and DEGs were selected for further analysis, including the generation of protein–protein interaction (PPI) network, miRNA–transcription factor–target regulatory network, and drug–gene network. A total of 264 DEGs and 40 DEMs were identified between the pAF and control groups. Functional and pathway enrichment analyses of up- and downregulated DEGs were performed. The common genes (CGs) were primarily enriched in the phosphoinositide 3-kinase- (PI3K-) protein kinase B (Akt) signaling pathway, negative regulation of cell division, and response to hypoxia. The PPI network, miRNA–transcription factor–target regulatory network, and drug–gene network were constructed using Cytoscape. The present study revealed several novel miRNAs and genes involved in pAF. We speculated that miR-4298, miR-3125, miR-4306, and miR-671-5p could represent significant miRNAs that act on the target gene superoxide dismutase 2 (SOD2) during the development of pAF and may serve as essential biomarkers for pAF diagnosis and treatment. Moreover, MYC might function in pAF pathogenesis through the PI3K–Akt signaling pathway.

Highlights

  • Atrial fibrillation (AF) is one of the most prevalent sustained arrhythmias, estimated to affect 34 million people worldwide, and the prevalence is increasing as the population ages [1]

  • Functional enrichment analysis indicated that the upregulated differentially expressed genes (DEGs) were primarily involved in biological process (BP) terms, such as signal transduction and immune response

  • In the cell component (CC) ontology, the upregulated DEGs were significantly enriched in extracellular exosome and extracellular region

Read more

Summary

Introduction

Atrial fibrillation (AF) is one of the most prevalent sustained arrhythmias, estimated to affect 34 million people worldwide, and the prevalence is increasing as the population ages [1]. Based on AF duration, AF can be divided into paroxysmal AF, persistent AF (pAF), long-standing pAF, and permanent AF [2]. The pathophysiological mechanisms of AF are complex and variable, and the pathogenesis of AF is still not fully understood [4]. Available drug therapies for patients with AF lack adequate efficacy and have been associated with potential adverse reactions. Ablation is typically more effective than drug therapy, this invasive procedure has considerable potential for complications and is limited by long-term recurrence [5]. The elucidation of the precise molecular mechanisms underlying AF is necessary for the development of novel diagnostic biomarkers and therapeutic targets

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.